ProShares UltraShort NASDAQ Biotechnology
4 hedge funds and large institutions have $71.6K invested in ProShares UltraShort NASDAQ Biotechnology in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$3.86K |
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$47 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$67.7K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $67.7K | 3,821 | -51 | -1% |
|
|
2
UBS Group
Zurich,
Switzerland
| $3.86K | 218 | +217 | +21,700% |
|
|
3
Morgan Stanley
New York
| $47 | 2 | -74 | -97% |
|
4
Simplex Trading
Chicago,
Illinois
| $0 | 5 | +5 | New |
|